Table 2:
Clustering | Relative Growth | Recent and Rapid Growth | |||||||
---|---|---|---|---|---|---|---|---|---|
c1% | c0.5% | g1.5% | g1% | g0.5% | RR2 | RR3 | RR4 | RR5 | |
Number of priority clusters | 407 | 269 | 3 | 5 | 24 | 71 | 27 | 14 | 7 |
Number of cases to be prioritized | 1499 | 838 | 158 | 154 | 152 | 283 | 161 | 94 | 51 |
Percent increase | 17.2 | 15.8 | 26.6 | 27.9 | 36.2 | 31.8 | 41.6 | 39.4 | 45.1 |
AGE AT DIAGNOSIS | |||||||||
14 - 19 | 4.1*** | 2.85*** | 2.22** | 3.02** | |||||
20 - 24 | 2.8*** | 2.04** | 1.64* | ||||||
25 - 29 | REF | REF | REF | REF | REF | REF | REF | REF | REF |
30 - 39 | |||||||||
40 - 49 | |||||||||
50 - 100 | 0.57* | ||||||||
RACE/ETHNICITY | |||||||||
African American | 0.62** | 0.55* | 0.6** | 0.6* | |||||
Latino | 0.52* | 0.09** | |||||||
White | REF | REF | REF | REF | REF | REF | REF | REF | REF |
Unknown | |||||||||
SEX/RISK GROUP | |||||||||
MSM | 1.51* | 6.43** | 2.16* | 4.06* | 7.6* | ||||
Female heterosexual | REF | REF | REF | REF | REF | REF | REF | REF | REF |
Female PWID | 0.28* | ||||||||
Female unknown risk | |||||||||
Male heterosexual | |||||||||
Male PWID | |||||||||
MSM/PWID | 6.84* | ||||||||
Male unknown risk |
Cluster prioritization schemes are defined in Table 1. Results are shown only if they were significant (p<0.05).
p<0.05
p<0.01
p<0.001. MSM: men who have sex with men, PWID: people who inject drugs.